MAGLIV-300 TAB contains Ursodeoxycholic Acid (UDCA) 300 mg, a bile acid medicine used in the management of certain liver and biliary conditions as prescribed by a healthcare professional.
Ursodeoxycholic Acid helps improve the composition and flow of bile and may be prescribed for selected cholestatic liver conditions and gallstone-related conditions. It works by modifying the bile acid pool and reducing the cholesterol saturation of bile in appropriate patients.
MAGLIV-300 TAB should be taken only according to the recommended dose and duration prescribed by the healthcare professional.
Composition
Ursodeoxycholic Acid IP — 300 mg
Indications / Uses
MAGLIV-300 TAB may be prescribed for:
- Certain cholestatic liver diseases
- Primary biliary cholangitis (PBC), where clinically appropriate
- Selected gallstone-related conditions
- Certain disorders associated with impaired bile flow
- Other hepatobiliary conditions as determined by a healthcare professional
Key Benefits
- Contains Ursodeoxycholic Acid 300 mg
- Supports healthy bile flow in appropriate clinical conditions
- Helps modify the composition of bile
- Used in the management of selected liver and biliary disorders
- Convenient tablet dosage form
Important Information
MAGLIV-300 TAB is a prescription medicine and should be used under medical supervision. The appropriate dose and treatment duration depend on the condition being treated. Regular medical monitoring may be required during prolonged treatment.
